Emerging Companies and Investors - Life Sciences and Health Care

We don't just get you off the ground; we're here to grow with you.

Subscribe to receive our insights.

From corporate formation to patent protection and strategy to initial financing rounds, we help your company lay a strong foundation, with life sciences and health care industry expertise at the forefront throughout. As your business grows and your needs evolve, so does our team of lawyers who can support your company’s strategic business needs relative to your product’s development stage, including regulatory approval planning, clinical trial design, pricing and reimbursement strategy, licensing, collaborations and other commercial transactions, and commercialization and product launch planning. And when the time comes, we’re prepared to support you in exit planning and execution through IPO, mergers and acquisitions, or asset monetization through strategic collaborations and cross-border licensing.

Key contacts

Kristin Anne Connarn

Partner

Kristin Anne Connarn

Partner

Boston

Beth L. Roberts

Partner

Beth L. Roberts

Partner

Washington, D.C.

Andrew L. Strong

Partner

Andrew L. Strong

Partner

Houston

Arne Thiermann, LL.M. (LSE)

Office Managing Partner

Arne Thiermann, LL.M. (LSE)

Office Managing Partner

Hamburg

Meet the Emerging Companies and Investors - Life Sciences and Health Care team

Representative experience

A radiopharmaceutical oncology company in connection with a large‑scale public financing, a strategic collaboration, facility acquisitions, manufacturing and research agreements, and other general corporate and transactional matters.

A biotechnology company in connection with its initial public offering, multiple public equity offerings, and private financing rounds.

An oncology-focused venture capital fund, partnered with a leading academic medical center, in connection with its formation and approval by a public university system.

Multiple therapeutic companies on their IP needs including patent prosecution, strategy, and transactional matters.

A range of life sciences companies on data privacy and security matters, including advising on international data protection, CCPA, data use agreements, and privacy policies and procedures, as well as performing comprehensive website reviews.

Medical device start up on due diligence to uncover several important FDA issues that substantially altered the investors valuation.

Multiple clients in the CAR-T space on manufacturing clinical trial and quality agreements, and regulatory and launch planning.

Multiple small companies on their participation in U.S. government funding programs (grants, cooperative agreements, contracts) for medical research and public health projects.